About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 9982 record(s)
Req # A-2020-00531
From April 1, 2020 to March 23, 2021, any record intended for the Minister's office that examines the possibility of creating a status of intermittent performer for Canadian artists.Organization: Canadian Heritage
April 2020
Req # A-2020-00535
From January 1, 2018 to March 29, 2021, any record pertaining to the construction of a baseball stadium in Montreal or of a return of Major League Baseball to Montreal.Organization: Canadian Heritage
April 2020
April 2020
Req # A-2021-00012
Briefing note to the Minister CH2021-00199: "Stakeholder Engagement for Economic Research in Support of Copyright".Organization: Canadian Heritage
April 2020
Req # A-2019-000354
All correspondence between FSD Pharma Inc. and Heath Canada from August 1, 2018 to June 4, 2019 regarding an application(s) for or issuing of any license(s) or permit(s).Organization: Health Canada
April 2020
Req # A-2019-000440
Any correspondence between any representative of Health Canada and any representative of Purdue Pharmaceutical or Purdue Pharma in regards to adverse reactions of OxyContin, including the adverse reaction of death.Organization: Health Canada
April 2020
Req # A-2019-000441
Any correspondence between Health Canada and any representative of Purdue Pharmaceutical in regards to any deceptive or manipulative marketing practices by the company in the sales of any of its products, in particular, of OyxContin by Purdue…Organization: Health Canada
April 2020
Req # A-2019-000958
All documents related to the natural health product licence submission, assessment, and decision for Ovomet.Organization: Health Canada
April 2020
Req # A-2019-001646
Adverse Reaction Report (AER) for HYDROCHLOROTHIAZIDE, IRBESARTAN. Report number: E2B_02372540.Organization: Health Canada
April 2020
Req # A-2019-001098
All correspondence records between any and/or all three Health Canada officials concerning the publication of the Draft Screening Assessment of Talc September 1, 2018 to December 31, 2018.Organization: Health Canada
April 2020